Revasc
Side effects
Options: Show MedDRA Preferred Terms
Indications
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||
|---|---|---|---|---|---|
| Deep vein thrombosis | x | x | x | ||
| Haemorrhage | x | x | |||
| Major bleed | x | x | |||
| Pulmonary embolism | x | x | |||
Color scheme:
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |
